Skip to main content

USIL Therapeutics

Luxembourg, Luxembourg

USIL Therapeutics is a biotechnology company focused on radiological preparedness.

$6.1M raised
May 2026
Grant

Top Investors

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about USIL Therapeutics

How much funding has USIL Therapeutics raised?
USIL Therapeutics has raised $6.1M in total funding. The most recent round was Grant. The last funding was announced in May 2026.
Who are USIL Therapeutics's investors?
USIL Therapeutics's investors include European Commission.
Where is USIL Therapeutics headquartered?
USIL Therapeutics is headquartered in Luxembourg, Luxembourg.
What does USIL Therapeutics do?
USIL Therapeutics is a biotechnology company focused on radiological preparedness.
What stage is USIL Therapeutics at?
USIL Therapeutics is at the Grant stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"USIL Therapeutics — Funding & Investors." VCBacked, May 5, 2026, https://www.vcbacked.co/company/usil-therapeutics. Accessed July 3, 2026.
APA
VCBacked. (2026). USIL Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/usil-therapeutics
Wikipedia (cite web)
{{cite web |title=USIL Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/usil-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .